CULVER CITY, CA--(Marketwired - Apr 24, 2017) - eWellness Healthcare Corporation (
Mr. Darwin Fogt, CEO, said "We are delighted to add the Jackson Clinics to our PHZIO beta group in order to assess the clinical value of our PHZIO treatment system. This beta user agreement is typical for a large scale physical therapy practice when testing a new treatment technique."
The PHZIO beta user agreement with Jackson Clinics calls for at least two physical therapists to utilize our PHZIO platform for 90-days for no-cost or obligation, in order to determine clinical value for their practices and patients. This trial period runs from April 24th, 2017 through July 31st, 2017. After July 31st, 2017, Jackson Clinics will have to sign a new agreement with the Company in order to continue to use our PHZIO system.
eWellness Healthcare Corporation (
The PHZIO Solution: A New Physical Therapy Delivery System
- SaaS technology platform solution for providers bundling rehabilitation services and employer wellness programs;
- First real-time remote monitored 1-to-many physical therapy treatment platform for home use;
- Ability for physical therapists to observe multiple patients simultaneously in real-time;
- Solves what has been a structural problem and limitation in post-acute care practice growth; and
- Allows PT practices to generate increased revenues due to higher adherence and compliance rates.
For more information on eWellness go to:
Safe Harbor Statement
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements (within the meaning of Section 27a of the Securities Act of 1933 and Section 21e of the Securities Exchange Act of 1934) regarding us and our business, financial condition, results of operations and prospects. Forward-looking statements in this press release reflect the good faith judgment of our management and are based on facts and factors currently known to us. Forward-looking statements are subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements as a result of either the matters set forth or incorporated in this press release generally or certain economic and business factors, some of which may be unknown to and/or beyond the control of the Company. Specifically, we are exposed to various risks related to our need for additional financing to support our technology development, the sale of a significant number of our shares of common stock could depress the price of our common stock, acquiring or investing in new businesses and ongoing operations, we may incur losses in the future and the market price of our common stock may be volatile. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. We do not undertake, and we expressly disclaim, any obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of the press release.